Annual Meeting of the Association for Applied Human Pharmacology

Log on / register
Feedback | Support | My details

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

Quick Search

	Annual Meeting of the Association for Applied Human Pharmacology
	Meeting Abstracts
	BioMed Central
	PubMed Central
	PubMed

Meetings

Meeting abstracts

Publish with us

Annual Meeting of the Association for Applied Human Pharmacology

2003 Annual Meeting of the Arbeitsgemeinschaft für Angewandte Humanpharmakologie (Association for Applied Human Pharmacology), Bonn, Germany, 23-25 February 2003

Oral presentation
Poster presentation

http://www.agah-web.de

Oral presentation [1-10] [11-20] [21-24]

11.	Oral presentation Socio-economic aspects of new drugs: what does the society want? Michael Schlander BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op011 [Abstract]
12.	Oral presentation Socio-economic aspects of new drugs: what can the society afford? Jens Gben BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op012 [Abstract]
13.	Oral presentation Exposure/Response vs. Dose/Response Relationships in Drug Development Bernd Meibohm BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op013 [Abstract]
14.	Oral presentation Using bioinformatics for bridging the genotype-phenotype gap Edgar Wingender BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op014 [Abstract]
15.	Oral presentation Xeloda, an old cytotoxic in a new form: new development paradigm required? Bruno Osterwalder BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op015 [Abstract]
16.	Oral presentation Safety, toxicity and efficacy of antineoplastic compounds a clinical view Dimitris Voliotis BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op016 [Abstract]
17.	Oral presentation Design and evaluation of clinical studies with angiogenesis inhibitors Dirk Laurent BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op017 [Abstract]
18.	Oral presentation Methods to assess the safety and efficacy of traditional compounds (NSAID, steroids) Kai Brune BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op018 [Abstract]
19.	Oral presentation Inflammatory bowel disease: Cytokines and cytokine therapies Markus F Neurath BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op019 [Abstract]
20.	Oral presentation Functional MRI in neurodegenerative disease Christian Gilles BMC Meeting Abstracts: 2003 Annual Meeting of the Arbeitsgemeinschaft fr Angewandte Humanpharmakologie (Association for Applied Human Pharmacology) 2003, 2:op020 [Abstract]

Annual Meeting of the Association for Applied Human Pharmacology Volumes

Volume 3 (2004)

Volume 2 (2003)

Volume 1 (2002)

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us